Kiromic Biopharma Stock Forecast - Naive Prediction

KRBPDelisted Stock  USD 2.68  0.07  2.55%   
The Naive Prediction forecasted value of Kiromic Biopharma on the next trading day is expected to be 2.65 with a mean absolute deviation of 0.26 and the sum of the absolute errors of 16.15. Kiromic Stock Forecast is based on your current time horizon.
  
A naive forecasting model for Kiromic Biopharma is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Kiromic Biopharma value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Kiromic Biopharma Naive Prediction Price Forecast For the 23rd of November

Given 90 days horizon, the Naive Prediction forecasted value of Kiromic Biopharma on the next trading day is expected to be 2.65 with a mean absolute deviation of 0.26, mean absolute percentage error of 0.12, and the sum of the absolute errors of 16.15.
Please note that although there have been many attempts to predict Kiromic Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Kiromic Biopharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Kiromic Biopharma Stock Forecast Pattern

Backtest Kiromic BiopharmaKiromic Biopharma Price PredictionBuy or Sell Advice 

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Kiromic Biopharma stock data series using in forecasting. Note that when a statistical model is used to represent Kiromic Biopharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria116.0024
BiasArithmetic mean of the errors None
MADMean absolute deviation0.2648
MAPEMean absolute percentage error0.0757
SAESum of the absolute errors16.1549
This model is not at all useful as a medium-long range forecasting tool of Kiromic Biopharma. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Kiromic Biopharma. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Kiromic Biopharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kiromic Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
2.682.682.68
Details
Intrinsic
Valuation
LowRealHigh
2.552.552.95
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Kiromic Biopharma. Your research has to be compared to or analyzed against Kiromic Biopharma's peers to derive any actionable benefits. When done correctly, Kiromic Biopharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Kiromic Biopharma.

View Kiromic Biopharma Related Equities

 Risk & Return  Correlation

Kiromic Biopharma Market Strength Events

Market strength indicators help investors to evaluate how Kiromic Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kiromic Biopharma shares will generate the highest return on investment. By undertsting and applying Kiromic Biopharma stock market strength indicators, traders can identify Kiromic Biopharma entry and exit signals to maximize returns.

Kiromic Biopharma Risk Indicators

The analysis of Kiromic Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Kiromic Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting kiromic stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Kiromic Biopharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kiromic Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiromic Biopharma will appreciate offsetting losses from the drop in the long position's value.

Moving together with Kiromic Stock

  0.66VALN Valneva SE ADRPairCorr

Moving against Kiromic Stock

  0.66DRUG Bright Minds BiosciencesPairCorr
  0.66SABSW SAB BiotherapeuticsPairCorr
  0.62VCYT VeracytePairCorr
  0.52DMAC DiaMedica Therapeutics Upward RallyPairCorr
  0.46VAXX VaxxinityPairCorr
The ability to find closely correlated positions to Kiromic Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kiromic Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kiromic Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kiromic Biopharma to buy it.
The correlation of Kiromic Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kiromic Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kiromic Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kiromic Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Consideration for investing in Kiromic Stock

If you are still planning to invest in Kiromic Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kiromic Biopharma's history and understand the potential risks before investing.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
CEOs Directory
Screen CEOs from public companies around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk